For in-vitro and laboratory research use only. Not for human or veterinary use. Nothing on this page is medical advice.
This short video explains CJC-1295 as a research compound. CJC-1295 is tetrasubstituted 29-Amino-Acid GHRH Receptor Agonist Analogue. It covers its molecular identity (CAS 863288-34-0, 3367.97 g/mol) and the pathways studied in laboratory models. A second video is included below.
In stock and UK lab tested
CJC-1295 without DACCJC-1295 with DACAll peptide videos| CAS number | 863288-34-0 |
|---|---|
| Molecular weight | 3367.97 g/mol |
| Sequence | Tyr-D-Ala2-Asp-Ala-Ile-Phe-Thr-Gln8-Ala15-Leu27-GHRH(1-29)-NH2 |
| Vial sizes | 2 mg · 5 mg · 10 mg Lyophilised Vials |
Each slide in the 60-second explainer follows one line of published laboratory work, not a medical outcome.
Every vial carries a report number. Match it to its certificate on the COA verification page before you start work. Lyophilised vials are best kept sealed, dry and at −20 °C or colder, away from light. Reconstitution and storage are covered step by step in our reconstitution and storage guide.
Corex Vitality™ supplies CJC-1295 strictly for in-vitro laboratory research by adults aged 18 or over. It is not a medicine, it is not for human or veterinary use, and no information on this page describes use in people or animals. Read the full terms of sale.
Research you can verify.
Get Corex Vitality™ Research Updates
Get new Learning Hub articles and stock updates. No spam. Unsubscribe any time.